Format

Send to

Choose Destination

Links from Structure

Oncogene. 2017 Sep 7;36(36):5177-5188. doi: 10.1038/onc.2017.137. Epub 2017 May 8.

Prolyl isomerase PIN1 regulates the stability, transcriptional activity and oncogenic potential of BRD4.

Author information

1
Department of Biochemistry, University of Illinois at Urbana-Champaign, Urbana, IL, USA.
2
Division of Translational Therapeutics, Department of Medicine, Beth Israel Deaconess Medical Center (BIDMC), Harvard Medical School, Boston, MA, USA.
3
The State Key Laboratory of Cellular Stress Biology, School of Life Sciences, Xiamen University, Xiamen, China.
4
Institute for Translational Medicine, Fujian Medical University, Fuzhou, China.
5
Department of Medical Biochemistry, College of Medicine, University of Illinois at Urbana-Champaign, Urbana, IL, USA.

Abstract

BRD4 has emerged as an important factor in tumorigenesis by promoting the transcription of genes involved in cancer development. However, how BRD4 is regulated in cancer cells remains largely unknown. Here, we report that the stability and functions of BRD4 are positively regulated by prolyl isomerase PIN1 in gastric cancer cells. PIN1 directly binds to phosphorylated threonine (T) 204 of BRD4 as revealed by peptide binding and crystallographic studies and enhances BRD4's stability by inhibiting its ubiquitination. PIN1 also catalyses the isomerization of proline 205 of BRD4 and induces its conformational change, which promotes its interaction with CDK9 and increases BRD4's transcriptional activity. Substitution of BRD4 with PIN1-binding-defective BRD4-T204A mutant in gastric cancer cells reduces BRD4's stability, attenuates BRD4-mediated gene expression by impairing its interaction with CDK9 and suppresses gastric cancer cell proliferation, migration and invasion, and tumor formation. Our results identify BRD4 as a new target of PIN1 and suggest that interfering with their interaction could be a potential therapeutic approach for cancer treatment.

PMID:
28481868
PMCID:
PMC5589477
DOI:
10.1038/onc.2017.137
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center